BeStock  
Stocks › Biotechnology › AVTX

Avalo Therapeutics AVTX

US equityMarket cap rank #3681Biotechnology
$6.76 +$0.01 (+0.15%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.76 0.00%
Open$6.65
Prev close$6.75
Day range$6.61 – $7.03
Volume1.18M
Market cap$390.88M
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts7
Average target$26.00+284.6% vs. price
  • Buy 71%
  • Hold 29%
Low $10.00Now $6.76Avg $26.00High $60.00

Recent rating changes

The last 20 actions on file set price targets from $10.00 to $60.00, averaging $29.76.

DateFirmRatingTarget
6 Nov 2026 BofA Securities BUY $24.00
6 Nov 2026 Wedbush BUY $20.00
6 Nov 2026 H.C. Wainwright HOLD –
5 Nov 2026 BTIG BUY $10.00
2 Nov 2026 BTIG BUY $10.00
26 Oct 2026 Oppenheimer BUY $16.00
23 Oct 2026 BTIG BUY $10.00
23 Oct 2026 Wedbush BUY $22.00
23 Oct 2026 Guggenheim HOLD –
23 Oct 2026 H.C. Wainwright HOLD $30.00
16 Oct 2026 H.C. Wainwright BUY $30.00
15 Oct 2026 H.C. Wainwright BUY $30.00
1 Oct 2026 Piper Sandler BUY $60.00
7 Aug 2026 BofA Securities BUY $35.00
7 Aug 2026 H.C. Wainwright BUY $30.00
6 Aug 2026 BTIG BUY $58.00
6 Aug 2026 Guggenheim BUY $48.00
6 Jul 2026 Leerink Partners BUY $38.00
12 Jun 2026 BofA Securities BUY $35.00
11 Jun 2026 TD Cowen BUY –

Discussion

No comments yet — be the first to weigh in on AVTX.

Sign in to join the discussion.

Scroll to Top